CellSource to Acquire Medibase as Unit; Shares Down 6%

MT Newswires Live2024-09-13

CellSource (TYO:4880), specializing in regenerative medicine, will acquire Medibase to integrate its cloud-based electronic medical record services, according to a Thursday filing on the Tokyo Stock Exchange.

Effective Sept. 12, the acquisition aims to develop CellSource's operations in regenerative medicine and explore new business opportunities in cosmetic surgery and dermatology.

The transaction is expected to have a minor impact on CellSource's current fiscal performance but should benefit long-term growth.

Shares of the company were down 6% in recent trade.

Price (JPY): $1296.00, Change: $-85, Percent Change: -6.15%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2467568766?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-13 09:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2467568766","market":"us","top_or_hot":-1,"title":"CellSource to Acquire Medibase as Unit; Shares Down 6%","media":"MT Newswires Live","content":"<html><body><p>CellSource to Acquire Medibase as Unit; Shares Down 6%</p><p> CellSource (TYO:4880), specializing in regenerative medicine, will acquire Medibase to integrate its cloud-based electronic medical record services, according to a Thursday filing on the Tokyo Stock Exchange.</p><p>Effective Sept. 12, the acquisition aims to develop CellSource's operations in regenerative medicine and explore new business opportunities in cosmetic surgery and dermatology.</p><p>The transaction is expected to have a minor impact on CellSource's current fiscal performance but should benefit long-term growth.</p><p>Shares of the company were down 6% in recent trade.</p><p>Price (JPY): $1296.00, Change: $-85, Percent Change: -6.15%</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CellSource to Acquire Medibase as Unit; Shares Down 6%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCellSource to Acquire Medibase as Unit; Shares Down 6%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-13 09:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>CellSource to Acquire Medibase as Unit; Shares Down 6% CellSource (TYO:4880), specializing in regenerative medicine, will acquire Medibase to integrate its cloud-based electronic medical record ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TYO","symbol_name":"3倍做空7-10年期国债ETF-Direxion","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2467568766","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467568766","pubTimestamp":1726192785,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"CellSource to Acquire Medibase as Unit; Shares Down 6% CellSource (TYO:4880), specializing in regene","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TYO":"3倍做空7-10年期国债ETF-Direxion"},"translate_title":"CellSource将收购Medibase作为一个单位；股价下跌6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TYO":1},"content_text":"CellSource to Acquire Medibase as Unit; Shares Down 6% CellSource (TYO:4880), specializing in regenerative medicine, will acquire Medibase to integrate its cloud-based electronic medical record services, according to a Thursday filing on the Tokyo Stock Exchange.Effective Sept. 12, the acquisition aims to develop CellSource's operations in regenerative medicine and explore new business opportunities in cosmetic surgery and dermatology.The transaction is expected to have a minor impact on CellSource's current fiscal performance but should benefit long-term growth.Shares of the company were down 6% in recent trade.Price (JPY): $1296.00, Change: $-85, Percent Change: -6.15%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2467568766","isCrawlerRequest":true}